Is it worthwhile rethinking the positive experience of the last 50 years of using chondroitin sulfates against atherosclerosis?
Chondroitin sulfate (CS) and glucosamine sulfate (GS) are used in the treatment of osteoarthritis and exhibit a pronounced anti-inflammatory effect. CS/GS inhibit the NF-kB signaling cascade, which realizes the biological effects of tumor necrosis factor (TNFa). Excessive activity of NF-kB also stim...
Saved in:
Main Authors: | A. M. Lila, I. Yu. Torshin, O. A. Gromova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2020-08-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/390 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospects for the use of chondroitin sulfate and glucosamine sulfate with osteoarthritis associated with pathology of the kidneys and urinary system
by: I. Yu. Torshin, et al.
Published: (2020-04-01) -
The results of postgenomic analysis of a glucosamine sulfate molecule indicate the prospects of treatment for comorbidities
by: I. Yu. Torshin, et al.
Published: (2018-12-01) -
Standardised Forms of Chondroitin Sulfate as a Pathogenetic Treatment of Osteoarthritis in the Context of Post-Genomic Studies
by: O. A. Gromova, et al.
Published: (2021-02-01) -
Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01) -
Comparative clinical and economic analysis of the use of symptomatic slow-acting drugs containing glucosamine sulfate in patients with Stage II gonarthrosis during outpatient care
by: I. V. Sarvilina, et al.
Published: (2019-12-01)